N.M.J. Rupniak

8.6k total citations
111 papers, 5.5k citations indexed

About

N.M.J. Rupniak is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, N.M.J. Rupniak has authored 111 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Cellular and Molecular Neuroscience, 56 papers in Molecular Biology and 22 papers in Physiology. Recurrent topics in N.M.J. Rupniak's work include Neuropeptides and Animal Physiology (44 papers), Receptor Mechanisms and Signaling (43 papers) and Neuroscience and Neuropharmacology Research (33 papers). N.M.J. Rupniak is often cited by papers focused on Neuropeptides and Animal Physiology (44 papers), Receptor Mechanisms and Signaling (43 papers) and Neuroscience and Neuropharmacology Research (33 papers). N.M.J. Rupniak collaborates with scholars based in United Kingdom, United States and Spain. N.M.J. Rupniak's co-authors include C. D. Marsden, Susan D. Iversen, Peter Jenner, Mark S. Kramer, Peter Jenner, M. J. Steventon, Angela Williams, J.K. Webb, S. Boyce and Emma Carlson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

N.M.J. Rupniak

110 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N.M.J. Rupniak United Kingdom	43	3.7k	2.3k	886	773	622	111	5.5k
Mark J. Millan France	47	4.5k 1.2×	2.8k 1.2×	808 0.9×	614 0.8×	826 1.3×	122	6.6k
Roser Cortés Spain	43	4.2k 1.1×	2.6k 1.1×	717 0.8×	575 0.7×	435 0.7×	92	5.8k
Françis C. Colpaert France	53	6.0k 1.6×	3.6k 1.5×	1.7k 2.0×	851 1.1×	605 1.0×	237	9.0k
G.N. Woodruff United Kingdom	43	6.3k 1.7×	4.2k 1.8×	1.1k 1.2×	535 0.7×	391 0.6×	151	8.0k
James K. Wamsley United States	49	5.0k 1.4×	3.6k 1.6×	888 1.0×	579 0.7×	722 1.2×	137	6.8k
Ezio Carboni Italy	38	4.3k 1.2×	2.4k 1.0×	567 0.6×	612 0.8×	453 0.7×	82	5.9k
John W. Kebabian United States	40	6.8k 1.9×	5.7k 2.5×	973 1.1×	1.1k 1.4×	536 0.9×	95	9.8k
D.J. Reis United States	52	3.9k 1.1×	2.8k 1.2×	1.6k 1.8×	566 0.7×	951 1.5×	132	8.0k
Laurence Lanfumey France	53	4.8k 1.3×	2.8k 1.2×	873 1.0×	406 0.5×	1.1k 1.7×	155	8.0k
G. L. Gessa Italy	38	3.3k 0.9×	1.6k 0.7×	604 0.7×	324 0.4×	519 0.8×	99	5.0k

Countries citing papers authored by N.M.J. Rupniak

Since Specialization

Citations

This map shows the geographic impact of N.M.J. Rupniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.M.J. Rupniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.M.J. Rupniak more than expected).

Fields of papers citing papers by N.M.J. Rupniak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N.M.J. Rupniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.M.J. Rupniak. The network helps show where N.M.J. Rupniak may publish in the future.

Co-authorship network of co-authors of N.M.J. Rupniak

This figure shows the co-authorship network connecting the top 25 collaborators of N.M.J. Rupniak. A scholar is included among the top collaborators of N.M.J. Rupniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N.M.J. Rupniak. N.M.J. Rupniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rupniak, N.M.J., Cristiana Griffante, Anna Sava, et al.. (2018). Affinity, potency, efficacy, and selectivity of neurokinin A analogs at human recombinant NK2 and NK1 receptors. PLoS ONE. 13(10). e0205894–e0205894. 11 indexed citations

Čulman, Juraj, Annegret Blume, Jürgen Hedderich, et al.. (2018). The Hypothalamic–Pituitary–Adrenal Axis and Serotonin Metabolism in Individual Brain Nuclei of Mice with Genetic Disruption of the NK1 Receptor Exposed to Acute Stress. Cellular and Molecular Neurobiology. 38(6). 1271–1281. 1 indexed citations

Guscott, Martin R., Linda J. Bristow, Karen L. Hadingham, et al.. (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology. 48(4). 492–502. 184 indexed citations

Rigby, Michael, Ruth O’Donnell, & N.M.J. Rupniak. (2005). Species differences in tachykinin receptor distribution: Further evidence that the substance P (NK₁) receptor predominates in human brain. The Journal of Comparative Neurology. 490(4). 335–353. 62 indexed citations

Maubach, Karen, Karine Martin, Gary G. Chicchi, et al.. (2002). Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus. Neuroscience. 109(3). 609–617. 60 indexed citations

Cheeta, Survjit, et al.. (2001). Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Research. 915(2). 170–175. 66 indexed citations

Rupniak, N.M.J., Emma Carlson, J.K. Webb, et al.. (2001). Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs. Behavioural Pharmacology. 12(6). 497–508. 125 indexed citations

Boyce, S., J.K. Webb, Sara L. Shepheard, et al.. (2000). Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats. Pain. 85(3). 443–450. 39 indexed citations

Smith, David W., Louise Hewson, Peter J. Fuller, et al.. (1999). The substance P antagonist L-760,735 inhibits stress-induced NK1 receptor internalisation in the basolateral amygdala. Brain Research. 848(1-2). 90–95. 67 indexed citations

10.

Webb, J.K., N.M.J. Rupniak, & S. Boyce. (1996). Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide. Regulatory Peptides. 61(1). 71–76. 5 indexed citations

11.

Rupniak, N.M.J., Emma Carlson, Susan Boyce, J.K. Webb, & R.G. Hill. (1996). Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils. Pain. 67(1). 189–195. 69 indexed citations

12.

Rupniak, N.M.J., J.K. Webb, Angela Williams, et al.. (1995). Antinociceptive activity of the tachykinin NK₁receptor antagonist, CP‐99,994, in conscious gerbils. British Journal of Pharmacology. 116(2). 1937–1943. 22 indexed citations

13.

Rupniak, N.M.J. & Anne Jackson. (1994). Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs. European Journal of Pharmacology. 262(1-2). 171–175. 19 indexed citations

14.

Rupniak, N.M.J., Nolwenn Samson, Spencer J. Tye, Mark J. Field, & Susan D. Iversen. (1991). Evidence against a specific effect of cholinergic drugs on spatial memory in primates. Behavioural Brain Research. 43(1). 1–6. 33 indexed citations

15.

Boyce, S., N.M.J. Rupniak, M. J. Steventon, & Susan D. Iversen. (1990). Characterisation of dyskinesias induced byl-dopa in MPTP-treated squirrel monkeys. Psychopharmacology. 102(1). 21–27. 47 indexed citations

16.

Boyce, S., N.M.J. Rupniak, M. J. Steventon, & Susan D. Iversen. (1990). Nigrostriatal Damage is Required for Induction of Dyskinesias by l-DOPA in Squirrel Monkeys. Clinical Neuropharmacology. 13(5). 448–458. 90 indexed citations

17.

Rupniak, N.M.J., Peter Jenner, & C. D. Marsden. (1986). Acute dystonia induced by neuroleptic drugs. Psychopharmacology. 88(4). 403–19. 159 indexed citations

18.

Rupniak, N.M.J., S. P. Mann, M.D. Hall, et al.. (1984). Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat. Psychopharmacology. 84(4). 503–511. 50 indexed citations

19.

Rupniak, N.M.J., S. Mansfield, Simon Fleminger, et al.. (1983). Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivity. European Journal of Pharmacology. 93(3-4). 195–200. 14 indexed citations

20.

Jenner, P, R Kerwin, N.M.J. Rupniak, et al.. (1983). Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.. PubMed. 18. 205–12. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact